COMP <GO>
INVE vs TACT // EV/EBITDA & P/E VALUATION
INVE Technologies Inc. (NASDAQ) VS. TransAct Technologies Incorporated (NASDAQ) • 15-METRIC TALLY: INVE 1
— TACT 9
■ METRIC PARITY
LAST: $2.68 (-0.37%) • MKT CAP: $65.0M
valuation
—
LAST: $5.59 (+1.64%) • MKT CAP: $57.7M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (INVE VS. TACT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | INVE | TACT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 6.10% | 48.60% | -42.50 | TACT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -10.50% | -24.50 | TACT | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -10.32% | 13.11% | -23.43 | TACT | /fcf-yield <GO> |
| Operating Margin | -60.00% | -2.70% | -57.30 | TACT | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -2.40% | -57.60 | TACT | /net-margins <GO> |
| Revenue Growth (YoY) | -19.30% | 18.70% | -38.00 | TACT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.07 | 4.37 | -3.30 | TACT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 7/9 | -5.00 | TACT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 60.6 | 63.0 | -2.42 | TACT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $65.0M | $57.7M | $7.2M | INVE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | INVE REV | TACT REV | INVE GROSS % | TACT GROSS % | INVE FCF | TACT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $21.5M | $51.5M | 6.1% | 48.6% | -$6.7M | $7.6M |
| FY 2024 | $26.6M | $43.4M | 1.3% | 49.5% | -$15.4M | $1.5M |
| FY 2023 | $43.4M | $72.6M | — | — | $1.2M | $5.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
INVE // BETA —
TACT // BETA —